Vitrakvi Capsule
Product Images NDC 50419-390

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Vitrakvi (NDC 50419-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 100 mg Carton Principal Panel (60 capsules)

VITRAKVI 100 mg capsules containing larotrectinib, an oral human prescription drug. The label states each capsule contains 100 mg larotrectinib (equivalent to 123 mg larotrectinib sulfate). The package includes 60 capsules. Labeler is Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

Image Of 25 mg Carton Principal Panel (60 capsules)

VITRAKVI 25 mg capsules containing larotrectinib are shown on the label. The label indicates that each capsule contains 25 mg of larotrectinib, equivalent to 30.7 mg of larotrectinib sulfate. The packaging design includes blue and yellow wave patterns and states the contents include 60 capsules for oral use. Bayer HealthCare Pharmaceuticals Inc. is the labeler.*

FDA Label Image

Image Of 20 mg/ml Carton Principal Panel (100 mL oral solution)

VITRAKVI (larotrectinib) oral solution 20 mg/mL label showing the product strength and volume. The label indicates each bottle contains 100 mL of 20 mg/mL larotrectinib oral solution, equivalent to 24.6 mg/mL larotrectinib sulfate. Manufactured by Bayer HealthCare Pharmaceuticals Inc.*

FDA Label Image

Image Of The Chemical Structure Of Vitrakvi (Chem Struct)

Chemical structure diagram of Larotrectinib, showing its molecular framework including fluorophenyl groups, pyrrolidine, and other molecular features, with a sulfate (H2SO4) component indicated.*

FDA Label Image

Image Of Supplies Needed To Take Or Give A Dose Of Vitrakvi Oral Solution (Fig A)

Illustration showing a bottle, a bottle adaptor, and two oral syringes labeled as 5 mL and 1 mL, respectively, likely used for administering a liquid medication. The 5 mL and 1 mL syringes are individually packaged in plastic wrappers.*

FDA Label Image

Image Of How To Open The Bottle (Fig B)

An instructional illustration labeled Figure B showing a hand gripping a bottle cap with arrows indicating the direction to turn and push, suggesting how to open the bottle.*

FDA Label Image

Image Of How To Insert The Adaptor Into The Bottle (Fig C)

An instructional illustration showing two bottles with labels, one with a cap removed and an arrow indicating placement of the cap onto the bottle, demonstrating how to properly close the bottle.*

FDA Label Image

Image Of The Oral Syringe And A Close Up Of The Markings In mL (Fig D)

Illustration showing the parts of a syringe, including the tip, barrel, flange, and plunger, with a close-up of the syringe barrel's graduated measurement markings.*

FDA Label Image

Image Of Of How To Insert The Oral Syringe Into The Bottle (Fig E)

An instructional illustration labeled Figure E showing a hand holding a vial on a flat surface, while another hand presses down a syringe plunger above the vial, indicating injection or withdrawal of liquid from the vial.*

FDA Label Image

Image Of How To Draw Vitrakvi Into The Oral Syringe For Proper Dose (Fig F)

An instructional illustration showing how to use a syringe to measure liquid medication. One hand holds a medication vial upside down with a syringe inserted for drawing the liquid, while the other hand stabilizes the syringe. A close-up diagram details the syringe parts: tip, plunger, barrel, and measurement markings up to 2 mL, indicating measurement to the top of the plunger.*

FDA Label Image

Image Of How To Expell Air Bubbles In The Oral Syringe (Fig G)

An instructional illustration labeled Figure G showing how to remove air bubbles from a syringe by holding a vial upside down and pulling back the syringe plunger to draw liquid. Arrows indicate the movement of air bubbles upward and out of the syringe.*

FDA Label Image

Image Of How To Remove The Oral Syringe From The Bottle (Fig H)

Illustration labeled Figure H showing a hand holding a syringe being pulled upward from a vial held by another hand, indicating the action of drawing fluid from the vial into the syringe.*

FDA Label Image

Image Of How To Properly Press The Plunger To Deliver The Dose (Fig I)

An instructional line drawing showing a hand holding a syringe or oral dosing device, positioned in front of a child's mouth, with an arrow indicating the direction to administer the dose orally.*

FDA Label Image

Image Of Recapping The Bottle (Fig J)

An instructional illustration demonstrating how to open a bottle with a child-resistant cap by twisting the cap in a counterclockwise direction while holding the bottle firmly. This image focuses on proper technique for opening the container.*

FDA Label Image

Image Of Removing The Plunger From The Barrel Of The Oral Syringe (Fig K)

An instructional diagram labeled Figure K showing two hands demonstrating the separation of a capsule into two parts, with arrows indicating the direction to pull each part apart. This likely illustrates how to open a VITRAKVI (larotrectinib) capsule.*

FDA Label Image

Image Of Rinsing The Oral Syringe (plunger And Barrel) (Fig L)

An instructional illustration showing a hand holding a syringe under running water from a faucet, with drops of liquid falling from both the syringe and a separate small cylindrical object. The image likely depicts rinsing or cleaning of these components.*

FDA Label Image

Image Of Re-insertion Of Plunger Into Oral Syringe Barrel (Fig M)

An instructional illustration labeled Figure M showing two numbered components of a syringe assembly. Component 1 is the plunger being pushed into the syringe barrel, and component 2 is the syringe barrel itself. The diagram appears to depict steps for using or preparing the syringe, related to VITRAKVI oral capsule administration.*

FDA Label Image

Image Of Cleaning Oral Syringe Using Warm Water (Fig N)

An instructional illustration showing two steps of syringe preparation or use. In step 1, a syringe is drawn upward, held by a hand above a dish. In step 2, another hand presses the syringe plunger downward, expelling liquid into the dish below.*

FDA Label Image

Image Of Rinsing The Plunger And Barrel Of The Oral Syringe A 2nd Time (Fig O)

An illustration showing a hand rinsing a small cylindrical container and a syringe under running water from a faucet, with drops falling from both items. This instructional image likely demonstrates a cleaning or rinsing step related to drug administration or preparation.*

FDA Label Image

Image Of Shaking Excess Water From The Barrel And Plunger (Fig P)

An instructional diagram showing a hand holding a syringe-like device, with arrows indicating movement directions. Drops are shown falling from the device, illustrating the expulsion or release of liquid.*

FDA Label Image

Image Of Where To Write The Date Of When The Bottle Was Opened (Fig Q)

An instructional illustration showing a person writing or labeling a date on a bottle using a pencil. The label on the bottle includes a space for the date to be recorded, exemplified by the handwritten date "4/17/20." This image demonstrates how to mark or track the date on medication packaging.*

FDA Label Image

Image Of 100 mg Label Principal Panel (60 capsules)

VITRAKVI 100 mg capsules label showing the generic name larotrectinib. The label includes dosage information, storage instructions, a Bayer logo, and a barcode. It states the product is manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, and provides details on capsule content and handling precautions.*

FDA Label Image

Image Of 25 mg Label Principal Panel (60 capsules)

VITRAKVI (larotrectinib) capsules label showing 25 mg strength. The label indicates prescription use, a package count of 60 capsules, storage instructions, and Bayer HealthCare Pharmaceuticals Inc. as the manufacturer. The label includes a barcode and the Bayer logo.*

FDA Label Image

Image Of 20 mg/ml Label Principal Panel (100 mL oral solution)

Label of VITRAKVI (larotrectinib) oral solution 20 mg/mL in a 100 mL bottle. The label includes dosage form oral solution, strength 20 mg/mL, and storage instructions to keep refrigerated at 2°C to 8°C. Manufactured by Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ. The Bayer logo is also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.